Professor Hang Hubert Yin was born in Beijing in 1976. After studying for a bachelor's degree at Peking University, he received his PhD from Yale University in 2004 under the supervision of Professor Andrew Hamilton and then spent a post-doctoral period at the University of Pennsylvania School of Medicine with Professor William DeGrado. In 2018, Professor Yin joined the School of Pharmaceutical Sciences at Tsinghua University as a founding Deputy Dean. Prior to joining Tsinghua, he was a tenured faculty member of the University of Colorado Boulder. Most recently, Professor Yin moved to Beijing Normal University as a University Distinguished Professor and the Founding Executive Director of the Institute for Advanced Study. He also serves as the Director of the Key Laboratory of Ministry of Education on Radiopharmaceuticals and the Director of Center of Biotechnology Frontiers at Beijing Normal University. His research interests lie at the interface of chemistry, biology, and engineering with particular focuses on structure-based drug design, extracellular vesicles, cell signaling biochemistry, biotechnology development, and membrane protein simulations. Professor Yin is a recipient of many accolades for his research in chemical biology and drug discovery, including the Wu Jieping-Paul Janssen Medical & Pharmaceutical Award, American Chemical Society David W. Robertson Award for Excellence in Medicinal Chemistry, OKeanos-CAPA Senior Investigator Award, National Science Fund for Distinguished Young Scholars, Beijing Outstanding Young Scientist, CAPA Distinguished Junior Faculty Award, NSF CAREER Award, AACR Gertrude B. Elion Cancer Research Award, Sidney Kimmel Scholars Award, and HHMI Collaborative Innovation Award among others. Professor Yin’s is currently serving as the Editor-in-Chief of the Journal of Extracellular Vesicles Bioorganic published by Wiley and Bioorganic & Medicinal Chemistry Letters published by Elsevier.